Katherine Gorrell joins BioStem as Chief Legal &Compliance Officer to oversee functions for Nasdaq uplisting. LakeShore Biopharma's merger with Oceanpine Skyline Inc. for a going-private transaction, valued at US$2.7 million, expected to close in Q3 2026.
